CVKD 8-K 2026-09-29
Cadrenal Therapeutics, Inc. (CVKD) 8-K dated 2026-09-29 — accession 0001213900-26-104647.
Cadrenal Therapeutics, Inc. (CVKD) is a biotechnology company listed on US.
Cadrenal Therapeutics, Inc. filed a 8-K on 2026-09-29. Accession 0001213900-26-104647.
This 8-K covers: Director/officer change (Item 5.02), Shareholder vote results (Item 5.07), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for CVKD is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The CVKD SEC hub lists recent forms. The stock page is the research view.